UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 182

Sortiert nach

Molecular pathogenesis of atypical CML, CMML and MDS/MPN-unclassifiable

International journal of hematology, 2015-03, Vol.101 (3), p.229-242

2015

Volltextzugriff (PDF)

Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders

Nature genetics, 2010-08, Vol.42 (8), p.722-726

2010

Volltextzugriff (PDF)

EZH2 mutational status predicts poor survival in myelofibrosis

Blood, 2011-11, Vol.118 (19), p.5227-5234

2011

Volltextzugriff (PDF)

Inactivation of polycomb repressive complex 2 components in myeloproliferative and myelodysplastic/myeloproliferative neoplasms

Blood, 2012-02, Vol.119 (5), p.1208-1213

2012

Volltextzugriff (PDF)

JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms

Nature genetics, 2009-04, Vol.41 (4), p.446-449

2009

Volltextzugriff (PDF)

Tracing the First Days of the SARS-CoV-2 Pandemic in Greece and the Role of the First Imported Group of Travelers

Microbiology spectrum, 2022-12, Vol.10 (6), p.e0213422-e0213422

2022

Volltextzugriff (PDF)

The JAK2 46/1 haplotype predisposes to MPL-mutated myeloproliferative neoplasms

Blood, 2010-06, Vol.115 (22), p.4517-4523

2010

Volltextzugriff (PDF)

Transcription factor mutations in myelodysplastic/myeloproliferative neoplasms

Haematologica (Roma), 2010-09, Vol.95 (9), p.1473-1480

2010

Volltextzugriff (PDF)

Myeloid Neoplasms with Isolated Isochromosome 17q: a yet to be Defined Entity

Mediterranean journal of hematology and infectious diseases, 2017-11, Vol.9 (1), p.e2017066-e2017066

2017

Volltextzugriff (PDF)

Genomics of Myeloproliferative Neoplasms

Journal of clinical oncology, 2017-03, Vol.35 (9), p.947-954

2017

Volltextzugriff (PDF)

Frequent CBL mutations associated with 11q acquired uniparental disomy in myeloproliferative neoplasms

Blood, 2009-06, Vol.113 (24), p.6182-6192

2009

Volltextzugriff (PDF)

Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders

Blood, 2005-09, Vol.106 (6), p.2162-2168

2005

Volltextzugriff (PDF)

Is JAK2 V617F mutation more than a diagnostic index?

Leukemia research, 2009-01, Vol.33 (1), p.67-73

2009

Volltextzugriff (PDF)

A Case Report of Chronic Myelogenous Leukemia Presenting as Blastic Crisis with a T-Cell Acute Lymphoblastic Leukemia Phenotype: Awareness of a Rare Entity

Acta haematologica, 2023-11, Vol.146 (6), p.530

2023

Volltextzugriff (PDF)

Is JAK2 V617F mutation more than a diagnostic index? A meta-analysis of clinical outcomes in essential thrombocythemia

Leukemia research, 2009-01, Vol.33 (1), p.67-73

2009

Volltextzugriff (PDF)

Real life treatment experience and outcome of consecutively hospitalised patients with SARS-CoV-2 pneumonia by Omicron-1 vs Delta variants

Infectious diseases (London, England), 2023-10, Vol.ahead-of-print (ahead-of-print), p.1-10

2023

Volltextzugriff (PDF)

A Study of Haemostatic Parameters in Patients with Philadelphia-Negative Myeloproliferative Neoplasms. Correlation with, Clinical, Laboratory, Molecular, and Treatment Characteristics

Blood, 2018-11, Vol.132 (Supplement 1), p.4304-4304

2018

Volltextzugriff (PDF)

Bone Marrow Ribonucleotide Reductase mRNA Levels and Methylation Status As a Prognostic Factor in Patients with Myelodysplastic Syndrome Treated with 5-Azacytidine

Blood, 2019-11, Vol.134 (Supplement_1), p.1721-1721

2019

Volltextzugriff (PDF)

Bone marrow ribonucleotide reductase mRNA levels and methylation status as prognostic factors in patients with myelodysplastic syndrome treated with 5-Azacytidine

Leukemia & lymphoma, 2022-02, Vol.63 (3), p.729-737

2022

Volltextzugriff (PDF)

PRR14L mutations are associated with chromosome 22 acquired uniparental disomy, age-related clonal hematopoiesis and myeloid neoplasia

Leukemia, 2019-05, Vol.33 (5), p.1184-1194

2019

Volltextzugriff (PDF)

Concurrent or Sequential BCR-ABL Translocation and Calr gene or JAK2V617F Mutation

Blood, 2014-12, Vol.124 (21), p.1844-1844

2014

Volltextzugriff (PDF)

Latent Myeloproliferative Neoplasm May Underlie Retinal Vein Occlusion In Older Patients

Blood, 2013-11, Vol.122 (21), p.5242-5242

2013

Volltextzugriff (PDF)

Minimal molecular response in polycythemia vera patients treated with imatinib or interferon alpha

Blood, 2006-04, Vol.107 (8), p.3339-3341

2006

Volltextzugriff (PDF)

Increased CD177 (PRV1) expression in thalassaemia and the underlying erythropoietic activity

British journal of haematology, 2008-04, Vol.141 (1), p.100-104

2008

Volltextzugriff (PDF)

1 – 25 von 182

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(173)
Mit Volltextzugriff
(171)

Publikationsform

Artikel
(179)
Berichte
(2)
Bücher
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Molecular pathogenesis of atypical CML, CMML and MDS/MPN-unclassifiable

Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders

EZH2 mutational status predicts poor survival in myelofibrosis

Inactivation of polycomb repressive complex 2 components in myeloproliferative and myelodysplastic/myeloproliferative neoplasms

JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms

Establishment of the first World Health Organization International Genetic Reference Panel for quantitation of BCR-ABL mRNA

Tracing the First Days of the SARS-CoV-2 Pandemic in Greece and the Role of the First Imported Group of Travelers

The JAK2 46/1 haplotype predisposes to MPL-mutated myeloproliferative neoplasms

Transcription factor mutations in myelodysplastic/myeloproliferative neoplasms

Myeloid Neoplasms with Isolated Isochromosome 17q: a yet to be Defined Entity

Genomics of Myeloproliferative Neoplasms

Frequent CBL mutations associated with 11q acquired uniparental disomy in myeloproliferative neoplasms

Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders

Is JAK2 V617F mutation more than a diagnostic index?

A Case Report of Chronic Myelogenous Leukemia Presenting as Blastic Crisis with a T-Cell Acute Lymphoblastic Leukemia Phenotype: Awareness of a Rare Entity

Is JAK2 V617F mutation more than a diagnostic index? A meta-analysis of clinical outcomes in essential thrombocythemia

Real life treatment experience and outcome of consecutively hospitalised patients with SARS-CoV-2 pneumonia by Omicron-1 vs Delta variants

A Study of Haemostatic Parameters in Patients with Philadelphia-Negative Myeloproliferative Neoplasms. Correlation with, Clinical, Laboratory, Molecular, and Treatment Characteristics

Bone Marrow Ribonucleotide Reductase mRNA Levels and Methylation Status As a Prognostic Factor in Patients with Myelodysplastic Syndrome Treated with 5-Azacytidine

Bone marrow ribonucleotide reductase mRNA levels and methylation status as prognostic factors in patients with myelodysplastic syndrome treated with 5-Azacytidine

PRR14L mutations are associated with chromosome 22 acquired uniparental disomy, age-related clonal hematopoiesis and myeloid neoplasia

Concurrent or Sequential BCR-ABL Translocation and Calr gene or JAK2V617F Mutation

Latent Myeloproliferative Neoplasm May Underlie Retinal Vein Occlusion In Older Patients

Minimal molecular response in polycythemia vera patients treated with imatinib or interferon alpha

Increased CD177 (PRV1) expression in thalassaemia and the underlying erythropoietic activity

Suchergebnisse filtern